| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2008 | CA2681635A1 Methods of suppressing ltp inhibition |
| 09/25/2008 | CA2681634A1 Methods and compositions related to riboswitches that control alternative splicing |
| 09/25/2008 | CA2681628A1 Inhibitors of cholesterol ester transfer protein |
| 09/25/2008 | CA2681526A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate |
| 09/25/2008 | CA2681521A1 Supramolecular complexes as photocatalysts for reduction of substrates |
| 09/25/2008 | CA2681516A1 Compounds useful as inhibitors of janus kinases |
| 09/25/2008 | CA2681506A1 Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| 09/25/2008 | CA2681505A1 Iejimalid analoga and uses thereof |
| 09/25/2008 | CA2681501A1 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 09/25/2008 | CA2681481A1 Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction |
| 09/25/2008 | CA2681476A1 Use of glucocorticoids for treatment of congestive heart failure |
| 09/25/2008 | CA2681466A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 09/25/2008 | CA2681409A1 Indolizine acetic acid derivatives as crth2 antagonists |
| 09/25/2008 | CA2681384A1 Method for treating cb2 receptor mediated pain |
| 09/25/2008 | CA2681381A1 Method for treating cb2 receptor mediated pain |
| 09/25/2008 | CA2681351A1 Inhibitors of fibroblast activation protein, and methods of use thereof |
| 09/25/2008 | CA2681326A1 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | CA2681323A1 Combined hairpin-antisense compositions and methods for modulating expression |
| 09/25/2008 | CA2681320A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | CA2681261A1 Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer |
| 09/25/2008 | CA2681260A1 Substituted tetrahydropyrroloquinolines |
| 09/25/2008 | CA2681256A1 Substituted pyranyl quinolines |
| 09/25/2008 | CA2681250A1 Chemical compounds |
| 09/25/2008 | CA2681222A1 Mannich base n-oxide drugs |
| 09/25/2008 | CA2681208A1 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 09/25/2008 | CA2681185A1 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 09/25/2008 | CA2681174A1 Magnesium compositions and uses thereof |
| 09/25/2008 | CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 09/25/2008 | CA2681015A1 Inhibitors of focal adhesion kinase |
| 09/25/2008 | CA2680854A1 Treatment method using egfr antibodies and src inhibitors and related formulations |
| 09/25/2008 | CA2680761A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | CA2680757A1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/25/2008 | CA2680756A1 Stabilization of vitamin b12 |
| 09/25/2008 | CA2680737A1 Allyloxy and alkyloxy benzoic acid delivery agents |
| 09/25/2008 | CA2680684A1 Solid preparation comprising 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1 (2h)-pyrimidinyl]methyl]-4-fluorobenzonitrile |
| 09/25/2008 | CA2680592A1 Desferrithiocin polyether analogues and uses thereof in treating pathological conditions |
| 09/25/2008 | CA2680587A1 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 09/25/2008 | CA2680398A1 Raf kinase inhibitors containing a zinc binding moiety |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/25/2008 | CA2680239A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/25/2008 | CA2680006A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 09/25/2008 | CA2679344A1 Photoreactive ru (ii) complexes anchored on oligonucleotides, method for obtaining them and use thereof |
| 09/25/2008 | CA2679260A1 Novel benzamide derivatives and process for the preparation thereof |
| 09/25/2008 | CA2679138A1 Amino-pyridine derivatives as s1p1/edg1 receptor agonists |
| 09/25/2008 | CA2678949A1 Biaryl and biheteroaryl compounds useful in treating iron disorders |
| 09/25/2008 | CA2678795A1 Antibacterial cyclohexylsulfanyl pleuromutilins |
| 09/25/2008 | CA2678168A1 Low molecular weight heparins including at least one covalent bond with biotin or a biotin derivative, method for making same and use thereof |
| 09/25/2008 | CA2678166A1 Heparins including at least one covalent bond with biotin or a biotin derivative, method for preparing same and use thereof |
| 09/25/2008 | CA2678042A1 Pharmaceutical composition containing phloroglucinol and paracetamol |
| 09/25/2008 | CA2677733A1 Conjugates of synthetic tlr agonists and uses therefor |
| 09/25/2008 | CA2676954A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 09/24/2008 | EP1972684A1 Medium for culturing autologous human progenitor stem cells and applications |
| 09/24/2008 | EP1972633A1 Antitumour compounds |
| 09/24/2008 | EP1972631A1 Imidazopyridazines as PI3K lipid kinase inhibitors |
| 09/24/2008 | EP1972630A1 Purines as cysteine protease inhibitors |
| 09/24/2008 | EP1972629A1 New imidazolo-heteroaryl derivatives with antibacterial properties |
| 09/24/2008 | EP1972628A1 Indolizines and aza-analog derivatives thereof as CNS active compounds |
| 09/24/2008 | EP1972627A1 Amino-napthyridine derivatives |
| 09/24/2008 | EP1972626A2 Process for producing scopine esters |
| 09/24/2008 | EP1972618A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 09/24/2008 | EP1972617A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors |
| 09/24/2008 | EP1972616A1 Derivatives of arylalkylcarbamates, process for their preparation and therapeutic application thereof |
| 09/24/2008 | EP1972615A1 Cycloalkanecarboxamide derivative and method for producing same |
| 09/24/2008 | EP1972611A1 Aryl dihydro-naphthalene compounds, their preparation and their use as akt inhibitor for the prevention and treatment of cancer |
| 09/24/2008 | EP1972344A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 09/24/2008 | EP1972341A1 Pharmaceutical compositions comprising a bisphosphonate and vitamin D |
| 09/24/2008 | EP1972340A2 Method of preparing an aqueous meloxicam solution and the resulting aqueous solution |
| 09/24/2008 | EP1972339A1 Haemostatic Compositions |
| 09/24/2008 | EP1972338A1 Anti-infective agents |
| 09/24/2008 | EP1972336A1 Hot-melt micropellets |
| 09/24/2008 | EP1972335A1 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 09/24/2008 | EP1972334A1 Emulsion Composition Comprising Prostaglandin E1 |
| 09/24/2008 | EP1972333A1 Stabilised aqueous solutions of ergolin compounds |
| 09/24/2008 | EP1972200A1 Fluid konjac material, method of producing the same and use thereof |
| 09/24/2008 | EP1971867A2 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 09/24/2008 | EP1971618A2 Modulators of hypoxia inducible factor-1 and related uses |
| 09/24/2008 | EP1971614A1 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors |
| 09/24/2008 | EP1971613A1 Crystalline form of vinflunine ditartrate |
| 09/24/2008 | EP1971612A1 8-pyrazinyl-s-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents |
| 09/24/2008 | EP1971610A1 Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
| 09/24/2008 | EP1971609A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 09/24/2008 | EP1971608A1 Spiroketals |
| 09/24/2008 | EP1971605A1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators |
| 09/24/2008 | EP1971604A2 Pyrrolo-pyridine derivatives for the treatment of cancer diseases |
| 09/24/2008 | EP1971603A2 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/24/2008 | EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 09/24/2008 | EP1971600A1 Isoxazole derivatives and use thereof |
| 09/24/2008 | EP1971599A1 Antiviral 2-carboxy-thiophene compounds |
| 09/24/2008 | EP1971598A1 Beta-secretase modulators and methods of use |
| 09/24/2008 | EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 09/24/2008 | EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 09/24/2008 | EP1971595A2 Cetp inhibitors |
| 09/24/2008 | EP1971594A2 Substituted pyrazalones |
| 09/24/2008 | EP1971593A2 Improved synthesis and preparations of duloxetine salts |
| 09/24/2008 | EP1971588A1 Tiglien-3-one derivatives |
| 09/24/2008 | EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/24/2008 | EP1971578A1 21-deoxymacbecin analogues useful as antitumor agents |
| 09/24/2008 | EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |